Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction vs Adjuvant Gemcitabine/Cisplatin in Nasopharyngeal Carcinoma
NCT04898374Phase 3Recruiting
- Sponsor
- Kuwait Cancer Control Center
- Start
- May 2021
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Kuwait Cancer Control Center. Started May 2021; status: recruiting.
02
Drugs
gemcitabinecisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT04898374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04898374.